A Study of Ranolazine in ALS
A Study of Ranolazine in ALS
Recruiting · NCT06527222 · Registry updated 2026-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Ranolazine in ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 2 | 2026-06-08 | NCT06527222 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ALS Association | 8 |
| Swathy Chandrashekhar, MBBS | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| The Ohio State University | Columbus | United States | 191 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Kansas Medical Center | Fairway | United States | 18 |
| University of Kansas Medical Center: Wichita | Wichita | United States | 1 |
| University of Missouri Health Care | Columbia | United States | 14 |